NBMPR from Tocris Bioscience, a Bio-Techne Brand | Biocompare.com

Supplier Images

NBMPR

Equilibrative nucleoside transporter 1 (ENT1) inhibitor

Be the first to write a review!

Citations:

Supplier Page from
Tocris Bioscience, a Bio-Techne Brand for
NBMPR

Description

Equilibrative nucleoside transporter 1 (ENT1) inhibitor

Product Specs
ItemNBMPR
CompanyTocris Bioscience, a Bio-Techne Brand
Price $114.00Supplier Page View Company Product Page
Catalog Number2924/50
Quantity50 mg
Purity98%
Molecular Weight419.41
Molecule Name6-S-[(4-Nitrophenyl)methyl]-6-thioinosine
FormulaC17H17N5O6S
StorageStore at +4°C

Specifications/Features

Sizes Available: 50 mg

Add to Compare List

Tocris Bioscience, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956
Fax: 1 (612) 656-4400

Company Profile

Website: http://www.tocris.com

(1) Investigation of the specificity and mechanism of action of the ULK1/AMPK inhibitor SBI-0206965The Biochemical journalAugust 13, 2021Ahwazi D, Neopane K, Markby GR, Kopietz F, Ovens AJ, Dall M, Hassing AS, Gräsle P, Alshuweishi Y, Treebak JT, et al.

(2) Physiology and effects of nucleosides in mice lacking all four adenosine receptorsPLoS biologyMarch 1, 2019Xiao C, Liu N, Jacobson KA, Gavrilova O, Reitman ML.

(3) Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelorBloodDecember 8, 2016Aungraheeta R, Conibear A, Butler M, Kelly E, Nylander S, Mumford A, Mundell SJ.

(4) The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosineCell death & diseaseFebruary 5, 2015Baron L, Gombault A, Fanny M, Villeret B, Savigny F, Guillou N, Panek C, Le Bert M, Lagente V, Rassendren F, et al.

(5) Chronic sleep restriction disrupts sleep homeostasis and behavioral sensitivity to alcohol by reducing the extracellular accumulation of adenosineThe Journal of neuroscience : the official journal of the Society for NeuroscienceJanuary 29, 2014Clasadonte J, McIver SR, Schmitt LI, Halassa MM, Haydon PG.

(6) CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinomaOncoimmunologyAugust 1, 2012Mandapathil M, Szczepanski M, Harasymczuk M, Ren J, Cheng D, Jackson EK, Gorelik E, Johnson J, Lang S, Whiteside TL.

Be the First to Write a Review!